The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1333
Addendum: Cost of Ustekinumab (Stelara)
Download PDF:   US English
Med Lett Drugs Ther. 2010 Mar 8;52(1333):20
Disclosures
Objective(s)
 Select a term to see related articles  2010   2010 Page 7   adalimumab   Addendum: Cost of Ustekinumab (Stelara) (Med Lett Drugs Ther 2010; 52:7)   Alefacept   Amevive   Biologics   calcipotriene   calcitriol   corticosteroids   Cost of Ustekinumab   Cost of Ustekinumab (Stelara)   cyclosporine   Dovonex   Enbrel   etanercept   Humira   infliximab   Interleukin antagonist   Issue 1330   Issue 1333   January 25   March 8   methotrexate   page 20   phototherapy   plaque psoriasis   Remicade   Stelara   tazarotene   Tazorac   ustekinumab   Ustekinumab (Stelara) for Psoriasis   Vectical   volume 52 

In the Medical Letter article on ustekinumab (Stelara) for psoriasis (2010; 52:7), footnote 2 in table 2 should have included a second sentence: $5595.60 is the cost of one 45-mg syringe.

© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
arrow to previous article
arrow to next article